Ticker Scorecard - BBIO Basics Company: BridgeBio Pharma, Inc. IPO Date: June 24, 2019 Sector: Healthcare Industry: Biotech Market Cap: $6.45B Activated in VL: True Average Daily Range Avg Daily Range: $0.84 | 3.16% Avg Daily Range (30 D): $0.86 | 2.57% Avg Daily Range (90 D): $0.81 | 2.64% Institutional Daily Volume Avg Daily Volume: 1.37M Avg Daily Volume (30 D): 2.61M Avg Daily Volume (90 D): 2.27M Trade Size Avg Trade Size (Sh.): 88 Avg Trade Size (Sh.) (30 D): 86 Avg Trade Size (Sh.) (90 D): 81 Institutional Trades Total Inst.Trades: 5,492 Avg Inst. Trade: $2.85M Avg Inst. Trade (30 D): $2.67M Avg Inst. Trade (90 D): $2.81M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $5.92M Avg Closing Trade (30 D): $10.87M Avg Closing Trade (90 D): $9.94M Avg Closing Volume: 234.65K     News Mar 21, 2025 @ 8:00 PM BridgeBio Pharma Reports Inducement Grants under N... Source: N/A Feb 26, 2025 @ 7:49 AM BridgeBio Prices Offering of $500 Million Converti... Source: N/A Jan 9, 2025 @ 6:00 PM Rare Endocrinology and Metabolic Disorders Market ... Source: Delveinsight Nov 23, 2024 @ 12:11 AM Attrubyâ„¢ (acoramidis), a Near Complete TTR S... Source: Bridgebio Pharma, Inc. Sep 11, 2024 @ 5:44 PM BridgeBio Pharma Seeks Partner To Develop Gene The... Source: Vandana Singh Financials   TTM Q4 2024 FY 2024 Basic EPS $-2.88 $-1.42 $-2.88 Diluted EPS $-2.88 $-1.42 $-2.88 Revenue $ 221.9M $ 5.88M $ 221.9M Gross Profit $ 218.02M $ 3.8M $ 218.02M Net Income / Loss $ -543.35M $ -267.39M $ -543.35M Operating Income / Loss $ -592.97M $ -226.03M $ -592.97M Cost of Revenue $ 3.88M $ 2.08M $ 3.88M Net Cash Flow $ 288.51M $ 275.37M $ 288.51M PE Ratio